GlassScriptPhysician profile
Nauman Jahangir
NPI 1326188558
$38,389.50
in general payments reported to CMS, 2019-2025
31 companies · $1,430 in 2025
The $1,430 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $3,989 · 2021: $1,049 · 2022: $1,673 · 2023: $2,551 · 2024: $1,379 · 2025: $1,430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,690 · Travel and Lodging: $670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,690.18 |
| Travel and Lodging | $670.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $25,021.70 | 2019-2020 | |
| Medtronic, INC. | $3,567.52 | 2021-2025 | Endurant Iis, Valiant Captivia, Heli-Fx Endoanchor System |
| Medtronic Vascular, INC. | $2,939.40 | 2019-2020 | |
| Atricure, INC. | $2,332.94 | 2019-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2), Atricure Cryoice Cryosphere Cryoablation System |
| Edwards Lifesciences Corporation | $745.50 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Mitris Resilia Mitral Valve, Konect Resilia |
| Penumbra, INC. | $687.96 | 2019-2021 | |
| Abbott Laboratories | $470.09 | 2022-2025 | Navitor, Mitraclip, 2nd Gen Centrimag Primary Console |
| Boston Scientific Corporation | $275.18 | 2019-2023 | Icefx Cryoablation System |
| Abiomed | $232.05 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $212.69 | 2024-2025 | Lifevest |
| W. L. Gore & Associates, INC. | $202.88 | 2022-2025 | Gore Tag Conformable Thoracic Endoprosthesis |
| Artivion, INC. | $200.06 | 2019-2021 | |
| Endologix LLC | $177.95 | 2025 | Alto Abdominal Stent Graft System |
| Smith+Nephew, INC. | $156.44 | 2022-2023 | Pico |
| Balt USA, LLC | $149.70 | 2023 | Prestige Coil System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $135.53 | 2025 | Nuvision Ice Catheter |
| Lsi Solutions INC | $135.37 | 2019-2024 | Cor-Knot |
| Pfizer INC. | $123.41 | 2019 | |
| Ethicon US, LLC | $118.08 | 2019-2024 | Vistaseal, Ethicon, Stratafix |
| Kiniksa Pharmaceuticals International, Plc | $117.89 | 2024 | Arcalyst |
| Cvrx, INC. | $95.47 | 2023-2025 | Barostim Neo System |
| Getinge USA Sales, LLC | $59.36 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $34.46 | 2023 | Keytruda |
| Kls-Martin L.P. | $31.60 | 2024-2025 | |
| Aroa Biosurgery Incorporated | $30.38 | 2025 | |
| Dilon Technologies, INC. | $28.84 | 2024 | Hemoblast Bellows |
| La Jolla Pharmaceutical Company | $28.70 | 2025 | Giapreza |
| Bard Access Systems, INC. | $26.61 | 2019 | |
| Lemaitre Vascular, INC. | $19.35 | 2024 | Tyke, Patch, Pledget and Intracardiac |
| Acera Surgical, INC. | $17.35 | 2025 | Restrata Wound Matrix |
| Octapharma USA, INC. | $15.04 | 2025 | Fibryga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nauman Jahangir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.